Trials / Conditions / Human Immunodeficiency Virus Type 1 (HIV-1)
Human Immunodeficiency Virus Type 1 (HIV-1)
4 registered clinical trials studyying Human Immunodeficiency Virus Type 1 (HIV-1).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following NCT05896748 | ViiV Healthcare | Phase 3 |
| Completed | A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Parti NCT05896761 | ViiV Healthcare | Phase 3 |
| Completed | Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combinatio NCT01837719 | Bristol-Myers Squibb | Phase 1 |
| Completed | Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Partic NCT00833482 | Bristol-Myers Squibb | Phase 1 |